by S Aquaro 2024 Cited by 32Also, Integrase strand transfer inhibitors (INSTIs) are the class of ARV drugs most recently approved by the FDA for the treatment of HIV-1 infections. INSTIs
by C Muccini 2024 Cited by 4INSTI drug and to the INSTI drug class. DR within the INSTI class was defined by the presence of at least low-level resistance to ≥1 drug
by M Li 2024 Cited by 22drugs, the IN strand transfer inhibitors (INSTIs). Collectively, these changes weaken chelation of the bound INSTI, leading to a reduction in
by BN Harding 2024 Cited by 7These findings suggest INSTI use may increase the risk of anaemia. If confirmed, screening for anaemia development in users of INSTIs may be beneficial.
Dolutegravir-lamivudine (Dovato, ViiV), INSTI/NRTI, Bictegravir-emtricitabine-TAF (Biktarvy, Gilead), INSTI/NRTI, .
Recommended ART regimens for treatment-naive patients with HIV infection are INSTI-based, and are as follows: drugs - darunavir
The newest class of antiretrovirals for all persons living with HIV are the integrase strand transfer inhibitors (INSTIs). Since 2024, five INSTIs have been introduced: raltegravir, elvitegravir, dolutegravir, bictegravir, and cabotegravir. The INSTIs have favorable pharmacokinetic and pharmacodynam
The newest class of antiretrovirals for all persons living with HIV are the integrase strand transfer inhibitors (INSTIs). Since 2024, five INSTIs have been introduced: raltegravir, elvitegravir, dolutegravir, bictegravir, and cabotegravir. The INSTIs have favorable pharmacokinetic and pharmacodynamic properties, which contribute to both their effectiveness and their ease of use. With the
by C Spitznagel 2024well as individual INSTI drugs. We compared the proportion of women with viral suppression at delivery between INSTIs and non-INSTIs as well between
Comments